{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:30Z","timestamp":1791357390201,"version":"4.3.1"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.brainresbull.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T02:03:50Z","timestamp":1455415430000},"page":"47-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P1","title":["The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-0859","authenticated-orcid":false,"given":"Oliver G.","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2016.02.002_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1369.065","article-title":"Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics","volume":"1074","author":"Abanades","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","article-title":"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users","volume":"27","author":"Abanades","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0015","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1073\/pnas.1204376109","article-title":"\u03b14\u03b2\u03b4 GABA(A) receptors are high-affinity targets for \u03b3-hydroxybutyric acid (GHB)","volume":"109","author":"Absalom","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0020","unstructured":"Ahmed K., 2003. \u2018Liquid ecstasy\u2019 to be banned as date rapes and deaths soar The Guardian [Online]. Available: http:\/\/www.theguardian.com\/news\/2003\/jun\/29\/crime.politics."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbr.2009.04.002","article-title":"Food restriction or sleep deprivation: which exerts a greater influence on the sexual behaviour of male rats?","volume":"202","author":"Alvarenga","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00414-014-1051-8","article-title":"Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs","volume":"129","author":"Andresen-Streichert","year":"2015","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/dta.254","article-title":"An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results","volume":"3","author":"Andresen","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0040","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0140-6736(05)66738-4","article-title":"GHB-sense and sociability","volume":"365","author":"Anon","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0045","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0050","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1360-0443.2011.03373.x","article-title":"Food and addiction\u2014sugars, fats and hedonic overeating","volume":"106","author":"Avena","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0055","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0028-3908(02)00026-6","article-title":"GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid","volume":"42","author":"Barbaccia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1615\/CritRevNeurobiol.v16.i12.70","article-title":"Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs","volume":"16","author":"Barbaccia","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2005.01.026","article-title":"Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative\/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines","volume":"49","author":"Barbaccia","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02791072.2007.10399870","article-title":"Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study","volume":"39","author":"Barker","year":"2007","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1081\/JA-200066866","article-title":"Patterns of simultaneous polysubstance use in Canadian rave attendees","volume":"40","author":"Barrett","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050092","article-title":"Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB)","volume":"127","author":"Beardsley","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0085","first-page":"426130","article-title":"Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment","volume":"2012","author":"Bellato","year":"2012","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","article-title":"High affinity binding sites for gamma-hydroxybutyric acid in rat brain","volume":"30","author":"Benavides","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0095","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/2001207a0","article-title":"Gamma-Hydroxybutyrate a normal brain metabolite","volume":"200","author":"Bessman","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.104.069682","article-title":"GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood\u2013brain barrier","volume":"311","author":"Bhattacharya","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/15563659709001238","article-title":"Chemical submission: GHB, benzodiazepines, and other knock out drops","volume":"35","author":"Bismuth","year":"1997","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5664\/jcsm.27994","article-title":"The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy","volume":"6","author":"Black","year":"2010","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5664\/jcsm.4598","article-title":"Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy","volume":"11","author":"Bogan","year":"2015","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0091270002239707","article-title":"The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects","volume":"43","author":"Borgen","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0091270003262795","article-title":"The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients","volume":"44","author":"Borgen","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0269881111421975","article-title":"Reconsidering GHB: orphan drug or new model antidepressant?","volume":"26","author":"Bosch","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0140","first-page":"53S","article-title":"Prosexual effects of gammahydroxybutyrate in healthy male subjects","volume":"75","author":"Bosch","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.07.167","article-title":"Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone","volume":"62","author":"Bosch","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.smrv.2011.09.001","article-title":"Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Boscolo-Berto","year":"2012","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00063110-200009000-00003","article-title":"Gamma hydroxybutyric acid (GHB): an increasing trend in drug abuse","volume":"7","author":"Boyce","year":"2000","journal-title":"Eur. J. Emerg. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0160","series-title":"Daughter's Death Prompts Fight on \u2018Date Rape\u2019 Drug","author":"Bradsher","year":"1999"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jat\/bkr023","article-title":"Pharmacokinetic properties of gamma-hydroxybutyrate (GHB) in whole blood, serum, and urine","volume":"36","author":"Brailsford","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jat\/28.8.625","article-title":"Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects","volume":"28","author":"Brenneisen","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100119304","article-title":"The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate","volume":"6","author":"Broughton","year":"1979","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2007.01.005","article-title":"Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder","volume":"17","author":"Brundin","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.drugalcdep.2012.12.023","article-title":"Sociodemographic and substance use characteristics of gamma hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity","volume":"131","author":"Brunt","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0190","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.2174\/13816128113199990624","article-title":"GHB, GBL and 1,4-BD addiction","volume":"20","author":"Brunt","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","article-title":"GHB pharmacology and toxicology: acute intoxication: concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome","volume":"13","author":"Busardo","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/j.1326-5377.2004.tb06295.x","article-title":"Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia","volume":"181","author":"Caldicott","year":"2004","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0205","first-page":"1315","article-title":"Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practice","volume":"19","author":"Caputo","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0210","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","article-title":"Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB","volume":"31","author":"Carter","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-009-1589-1","article-title":"Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers","volume":"206","author":"Carter","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2008.10.003","article-title":"Behavioral analyses of GHB: receptor mechanisms","volume":"121","author":"Carter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","article-title":"Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse","volume":"104","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-328X(00)00078-4","article-title":"Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain","volume":"78","author":"Castelli","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0235","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","article-title":"Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"87","author":"Castelli","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0240","first-page":"861","article-title":"Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate","volume":"39","author":"Centers For Disease Control and Prevention","year":"1990","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0245","first-page":"281","article-title":"Gamma hydroxy butyrate use\u2014New York and Texas, 1995\u20131996","volume":"4","author":"Centers For Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0250","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3109\/10826084.2015.1013135","article-title":"Significant misuse of sildenafil in London nightclubs","volume":"50","author":"Chan","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0255","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2015.06.004","article-title":"Bidirectional association between depression and fibromyalgia syndrome: a nationwide longitudinal study","volume":"16","author":"Chang","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0260","first-page":"380","article-title":"Acute poisoning from gamma-hydroxybutyrate in California","volume":"156","author":"Chin","year":"1992","journal-title":"West. J. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0265","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0196-0644(98)70230-6","article-title":"Clinical course of gamma-hydroxybutyrate overdose","volume":"31","author":"Chin","year":"1998","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0270","doi-asserted-by":"crossref","first-page":"e79062","DOI":"10.1371\/journal.pone.0079062","article-title":"\u03b3-Hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors","volume":"8","author":"Connelly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neubiorev.2015.03.012","article-title":"Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use","volume":"53","author":"Corkery","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0280","first-page":"2205","article-title":"Utilisation en psychiatrie du gamma-OH","volume":"70","author":"Danon-Boileau","year":"1962","journal-title":"Presse Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0376-8716(02)00017-0","article-title":"GHB use among Australians: characteristics: use patterns and associated harm","volume":"67","author":"Degenhardt","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.drugpo.2007.08.007","article-title":"The epidemiology of GHB and ketamine use in an Australian household survey","volume":"19","author":"Degenhardt","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0295","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/recl.18900090403","article-title":"Le glycol t\u00e9tram\u00e9thyl\u00e9nique","volume":"9","author":"Dekkers","year":"1890","journal-title":"Recl. Trav. Chim. Pays-Bas"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0300","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5664\/jcsm.2924","article-title":"Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate","volume":"9","author":"Donjacour","year":"2013","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0305","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5665\/sleep.3592","article-title":"Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study","volume":"37","author":"Donjacour","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2869.2011.00943.x","article-title":"Severe fatigue in narcolepsy with cataplexy","volume":"21","author":"Droogleever Fortuyn","year":"2012","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0315","first-page":"73","article-title":"Contribution to the study of sodium 4-hydroxybutyrate (4ho) in the treatment of acute anxiety states","volume":"5","author":"Ducouedic","year":"1964","journal-title":"Agressologie"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0320","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","article-title":"Gamma-hydroxybutyrate: a health-food product producing coma and seizurelike activity","volume":"9","author":"Dyer","year":"1991","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00952990902933852","article-title":"Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study","volume":"35","author":"Elsing","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jat\/23.3.141","article-title":"Prevalence of drugs used in cases of alleged sexual assault","volume":"23","author":"ElsohlY","year":"1999","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0335","unstructured":"EMCDDA 2008. GHB and its precursor GBL: an emerging trend case study. In: ADDICTION, E. M. C. F. D. A. D. (ed.), Lisbon."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0340","series-title":"Thematic Papers\u2014GHB and its Precursor GBL: An Emerging Trend Case Study","author":"EMCDDA","year":"2011"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0345","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00173208","article-title":"Gamma-hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors","volume":"348","author":"Engberg","year":"1993","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10826089109056241","article-title":"Mortality in patients with substance abuse: a follow-up in Stockholm County, 1973\u20131984","volume":"26","author":"Engstrom","year":"1991","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0355","first-page":"447","article-title":"Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats","volume":"24","author":"Fadda","year":"1989","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0360","unstructured":"FDA 2002. FDA Approval letter for Xyrem: Indication: Cataplexy associated with narcolepsy. Available: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2002\/21196ltr.pdf."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0365","unstructured":"FDA 2006. FDA Approval letter for Xyrem: Indication: Excessive Daytime Sleepiness associated with narcolepsy. Available: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2005\/021196s005ltr.pdf."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0370","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2125.1992.tb04129.x","article-title":"Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses","volume":"34","author":"Ferrara","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002280050113","article-title":"Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid","volume":"50","author":"Ferrara","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0380","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s002280050560","article-title":"Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers","volume":"54","author":"Ferrara","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0385","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/emj.2008.068403","article-title":"Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients","volume":"28","author":"Galicia","year":"2011","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0390","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(89)90842-8","article-title":"Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome","volume":"2","author":"Gallimberti","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0395","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/npp.1993.45","article-title":"Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome","volume":"9","author":"Gallimberti","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02191883","article-title":"Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal","volume":"244","author":"Gallimberti","year":"1994","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0410","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(94)90911-3","article-title":"Physical dependence on sodium oxybate","volume":"343","author":"Galloway","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0415","first-page":"89","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0420","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000151683","article-title":"Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia","volume":"26","author":"Gao","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0425","unstructured":"GDS 2014. The highway code. The guide to safer, more enjoyable drug use. GHB: Global Drug Survey."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0430","unstructured":"GDS 2014. There\u2019s more to G than cock. In: Survey, G.D. (ed.)."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0435","first-page":"331","article-title":"On the toxic reactions of unsaturated lactones and their saturated analogs","volume":"6","author":"Giacomino","year":"1947","journal-title":"Fed. Proc."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0440","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03190843","article-title":"Metabolism of [U-14C]-4-hydroxybutyric acid to intermediates of the tricarboxylic acid cycle in extracts of rat liver and kidney mitochondria","volume":"14","author":"Gibson","year":"1989","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0445","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1081\/JA-200066886","article-title":"The relationship between club drug use and other drug use: a survey of New York City middle school students","volume":"40","author":"Goldsamt","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00213-005-2165-y","article-title":"Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons","volume":"180","author":"Goodwin","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0455","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-009-1477-8","article-title":"Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons","volume":"204","author":"Goodwin","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0460","first-page":"217","article-title":"Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons","volume":"114","author":"Goodwin","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0465","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00213-012-2851-5","article-title":"Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons","volume":"225","author":"GoodWin","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0470","unstructured":"Govuk 2015. Circular 001\/2015: a Change to the Misuse of Drugs Act 1971: control of AH-7921, LSD\u2014related compounds, tryptamines, and rescheduling of GHB. Available: https:\/\/www.gov.uk\/government\/publications\/circular-0012015-a-change-to-the-misuse-of-drugs-act-1971-control-of-ah-7921-lsd-related-compounds-tryptamines-and-rescheduling-of-ghb."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0475","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0733-8627(05)70150-4","article-title":"New drugs of abuse","volume":"18","author":"Graeme","year":"2000","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0480","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/10826080802484702","article-title":"Polydrug use among club-going young adults recruited through time-space sampling","volume":"44","author":"Grov","year":"2009","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bja\/43.2.113","article-title":"Effect of methohexitone: diazepam and sodium 4-hydroxybutyrate on short-term memory","volume":"43","author":"Grove-White","year":"1971","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0490","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.addbeh.2006.01.009","article-title":"GHB use among gay and bisexual men","volume":"31","author":"Halkitis","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0495","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.12.028","article-title":"Poly-club-drug use among gay and bisexual men: a longitudinal analysis","volume":"89","author":"Halkitis","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0500","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/10826080701801337","article-title":"Multivariate modeling of club drug use initiation among gay and bisexual men","volume":"43","author":"Halkitis","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0505","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-4159.1991.tb02012.x","article-title":"Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study","volume":"56","author":"Hechler","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0510","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-196411000-00007","article-title":"Correlation of blood levels of 4-hydroxybutyrate with state of consciousness","volume":"25","author":"Helrich","year":"1964","journal-title":"Anesthesiology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0515","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/head.12068","article-title":"Efficiency of sodium oxybate in episodic cluster headache","volume":"53","author":"Hidalgo","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0520","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1210\/jcem-49-2-197","article-title":"Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy","volume":"49","author":"Higuchi","year":"1979","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0525","first-page":"93","article-title":"Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man","volume":"6","author":"Hoes","year":"1980","journal-title":"Encephale"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/10550490500419144","article-title":"Club drug use among youths in treatment for substance abuse","volume":"15","author":"Hopfer","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0535","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1360-0443.2011.03613.x","article-title":"Mortality among substance-using mothers in California: a 10-year prospective study","volume":"107","author":"Hser","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0540","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnsys.2014.00216","article-title":"The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors","volume":"8","author":"Hurley","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0545","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sleep.2008.05.012","article-title":"Weight loss in narcolepsy patients treated with sodium oxybate","volume":"10","author":"Husain","year":"2009","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0550","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1079\/PNS2002179","article-title":"The evolution of the control of food intake","volume":"61","author":"Illius","year":"2002","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0555","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0736-4679(00)00188-8","article-title":"Coma and respiratory depression following the ingestion of GHB and its precursors: three cases","volume":"19","author":"Ingels","year":"2000","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0560","first-page":"166","article-title":"Behavioral and EEG effects of gammabutyrolactone and gamma-hydroxybutyric acid in man","volume":"4","author":"Jenney","year":"1962","journal-title":"Pharmacologist"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0565","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1046\/j.1365-2044.1998.00603.x","article-title":"Gamma-hydroxybutyric acid: an emerging recreational drug","volume":"53","author":"Kam","year":"1998","journal-title":"Anaesthesia"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0570","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/JCP.0000000000000315","article-title":"Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series","volume":"35","author":"Kamal","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Part 1","key":"10.1016\/j.brainresbull.2016.02.002_bib0575","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.clinthera.2009.07.005","article-title":"A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia","volume":"31","author":"Kantrowitz","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0580","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hup.2491","article-title":"Enhancing sexual desire and experience: an investigation of the sexual correlates of gamma-hydroxybutyrate (GHB) use","volume":"30","author":"Kapitany-Foveny","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0585","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000433-200109000-00013","article-title":"GHB. Club drug or confusing artifact?","volume":"22","author":"Karch","year":"2001","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0590","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1471-4159.1988.tb03071.x","article-title":"Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme","volume":"51","author":"Kaufman","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0595","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1211\/0022357011775460","article-title":"The urinary excretion of gamma-hydroxybutyric acid in man","volume":"53","author":"Kavanagh","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0600","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11524-006-9057-2","article-title":"Prevalence and predictors of club drug use among club-going young adults in New York city","volume":"83","author":"Kelly","year":"2006","journal-title":"J. Urban Health"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14728222.9.1.153","article-title":"GABA and glutamate systems as therapeutic targets in depression and mood disorders","volume":"9","author":"Kendell","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1212\/WNL.0b013e31822313c6","article-title":"Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache","volume":"77","author":"Khatami","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0615","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/00952990701312316","article-title":"High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users","volume":"33","author":"Kim","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0620","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neurobiolaging.2014.10.003","article-title":"Gamma-hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease","volume":"36","author":"Klein","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0625","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15563650701263633","article-title":"High mortality rates among GHB abusers in Western Sweden","volume":"46","author":"Knudsen","year":"2008","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0630","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1399-6576.2010.02278.x","article-title":"Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007","volume":"54","author":"Knudsen","year":"2010","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0635","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000353237","article-title":"Risk factors of gamma-hydroxybutyrate overdosing","volume":"20","author":"Korf","year":"2014","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0640","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/15563650.2011.576253","article-title":"Gamma-hydroxybutyrate: experience of 9 years of gamma-hydroxybutyrate (GHB)-related incidents during rave parties in The Netherlands","volume":"49","author":"Krul","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00414-008-0299-2","article-title":"Forensic toxicology findings in deaths involving gamma-hydroxybutyrate","volume":"124","author":"Kugelberg","year":"2010","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0650","first-page":"549","article-title":"Use of sodium 4-hydroxybutyrate in anesthesia and resuscitation","volume":"1","author":"Laborit","year":"1960","journal-title":"Agressologie"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0655","first-page":"51","volume":"3","author":"Laborit","year":"1972","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0660","first-page":"431","article-title":"Action du g-hydroxybutyrate de sodium sur les syndrome n\u00e9vrotiques et psychopathiques avec agitation psychomotrices","volume":"1","author":"Langlois","year":"1960","journal-title":"Agressologie"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0665","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/sleep\/13.1.24","article-title":"The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms","volume":"13","author":"Lapierre","year":"1990","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0670","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1227\/00006123-198304000-00010","article-title":"Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained awake rat","volume":"12","author":"Lavyne","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0675","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/02791072.2008.10400639","article-title":"Gamma hydroxybutyrate: an ethnographic study of recreational use and abuse","volume":"40","author":"Lee","year":"2008","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0680","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","volume":"2","author":"Leone","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0685","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/YCO.0b013e3282f9b1f1","article-title":"Ecstasy and other club drugs: a review of recent epidemiologic studies","volume":"21","author":"Leung","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0690","unstructured":"LGOVUK 2011. The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2011 No. 448. LGOVUK [Online]. Available: http:\/\/www.legislation.gov.uk\/uksi\/2011\/448\/made?view=plain."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0695","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","article-title":"Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy","volume":"14","author":"Liblau","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0700","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4414\/smw.2004.10697","article-title":"Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre","volume":"134","author":"Liechti","year":"2004","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0705","article-title":"Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyrate in healthy subjects","author":"Liechti","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0710","first-page":"53","article-title":"Effect of sodium oxybutyrate on metabolic indices in ischemic hypoxia of muscle tissue","volume":"47","author":"Lopatin","year":"1984","journal-title":"Farmakol. Toksikol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0715","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/15563659709001237","article-title":"A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol","volume":"35","author":"Louagie","year":"1997","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0720","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2105\/AJPH.82.1.128-a","article-title":"GHB use in South Carolina","volume":"82","author":"Luby","year":"1992","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0725","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(73)90839-8","article-title":"Sleep-inducing effects of gammahydroxybutyrate","volume":"2","author":"Mamelak","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0730","first-page":"273","article-title":"The effects of gamma-hydroxybutyrate on sleep","volume":"12","author":"Mamelak","year":"1977","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0735","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2006.06.008","article-title":"Alzheimer' s disease: oxidative stress and gammahydroxybutyrate","volume":"28","author":"Mamelak","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0740","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pneurobio.2009.07.004","article-title":"Narcolepsy and depression and the neurobiology of gammahydroxybutyrate","volume":"89","author":"Mamelak","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0745","first-page":"236","article-title":"Actions and interactions with alcohol of drugs on psychomotor skills: comparison of diazepam and gamma-hydroxybutyric acid","volume":"234","author":"Mattila","year":"1978","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0750","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0899-3289(01)00060-8","article-title":"Circuit party attendance, club drug use, and unsafe sex in gay men","volume":"13","author":"Mattison","year":"2001","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0755","first-page":"1245","article-title":"How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria","volume":"48","author":"Maurice-Tison","year":"1998","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0760","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1081\/JA-200066736","article-title":"Party drugs: properties, prevalence, patterns, and problems","volume":"40","author":"Maxwell","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0765","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1081\/JA-200066968","article-title":"Profiles of club drug users in treatment","volume":"40","author":"Maxwell","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0770","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF03327484","article-title":"Night eating syndrome. Preliminary results","volume":"5","author":"Mazzetti Di Pietralata","year":"2000","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0775","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/eat.20798","article-title":"Sodium oxybate in the treatment of binge eating disorder: an open-label prospective study","volume":"44","author":"Mcelroy","year":"2011","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0780","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/bjp.2008.132","article-title":"From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?","volume":"154","author":"Mcgregor","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0785","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/pgmj.67.785.297","article-title":"Disseminated gonococcal infection associated with deficiency of the second component of complement","volume":"67","author":"Mcwhinney","year":"1991","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0790","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1523\/JNEUROSCI.3127-12.2013","article-title":"The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study","volume":"33","author":"Mednick","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0795","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0013-4694(66)90107-6","article-title":"An EEG-behavioral study of sodium hydroxybutyrate in humans","volume":"20","author":"Metcalf","year":"1966","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0800","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/105504901750532111","article-title":"Gamma-hydroxybutyric acid: patterns of use effects and withdrawal","volume":"10","author":"Miotto","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0805","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3899\/jrheum.091041","article-title":"Effects of sodium oxybate on sleep physiology and sleep\/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study","volume":"37","author":"Moldofsky","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0810","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2009.05.017","article-title":"gamma-Hydroxybutyrate (GHB) induces GABA(B) receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABA(B) receptors of medium spiny neurons in the nucleus accumbens","volume":"162","author":"Molnar","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0815","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrn3745","article-title":"Neurobiology of food intake in health and disease","volume":"15","author":"Morton","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0820","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1097-4679(198901)45:1<51::AID-JCLP2270450107>3.0.CO;2-H","article-title":"Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients","volume":"45","author":"Mosko","year":"1989","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0825","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S0140525X11000057","article-title":"Drugs as instruments: a new framework for non-addictive psychoactive drug use","volume":"34","author":"Muller","year":"2011","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1742-6723.2008.01140.x","article-title":"Gamma-hydroxybutyrate: a 30 month emergency department review","volume":"20","author":"Munir","year":"2008","journal-title":"Emerg. Med. Australas."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0835","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1471-4159.1981.tb04689.x","article-title":"The extraneuronal distribution of gammahydroxybutyrate","volume":"37","author":"Nelson","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0840","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/0269881110363315","article-title":"The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review","volume":"24","author":"Nemeth","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0845","unstructured":"NIDA 2015. Club Drug. Available: http:\/\/www.drugabuse.gov\/drugs-abuse\/club-drugs."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0850","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.euroneuro.2011.05.004","article-title":"ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin","volume":"21","author":"Nutt","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0855","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-244X-11-122","article-title":"Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970\u20132006","volume":"11","author":"Nyhlen","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0860","first-page":"2478","article-title":"Gamma-hydroxybutyrate (GHB): a newer drug of abuse","volume":"62","author":"O'ConnelL","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0865","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/FBP.0b013e32833b3397","article-title":"Behavioral effects of gamma-hydroxybutyrate in humans","volume":"21","author":"Oliveto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0870","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.phrs.2006.12.002","article-title":"Preference for palatable food is reduced by the gamma-hydroxybutyrate analogue GET73 in rats","volume":"55","author":"Ottani","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0875","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2005.11.002","article-title":"A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes","volume":"17","author":"Palamar","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0880","first-page":"143","article-title":"A qualitative descriptive study of perceived sexual effects of club drug use in gay and bisexual men","volume":"5","author":"Palamar","year":"2014","journal-title":"Psychol. Sex."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0885","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00265954","article-title":"Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers","volume":"45","author":"Palatini","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0890","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/09540121.2011.565027","article-title":"Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City","volume":"23","author":"Pappas","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0895","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00439451","article-title":"Stereospecific actions of baclofen on sociosexual behavior: locomotor activity and motor execution","volume":"97","author":"Paredes","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0900","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/02791072.2004.10400030","article-title":"Club drugs: reasons for and consequences of use","volume":"36","author":"Parks","year":"2004","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0905","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuroscience.2004.11.021","article-title":"Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects","volume":"131","author":"Pistis","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0910","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.sleep.2014.04.020","article-title":"Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy","volume":"15","author":"Plazzi","year":"2014","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0915","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.drudis.2014.08.017","article-title":"Ketamine: repurposing and redefining a multifaceted drug","volume":"19","author":"Potter","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0920","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bcp.12632","article-title":"Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers","volume":"80","author":"Pross","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0925","doi-asserted-by":"crossref","first-page":"e1428","DOI":"10.4088\/JCP.14m09009","article-title":"Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009\u20132010 National Health and Nutrition Examination Survey (NHANES)","volume":"75","author":"Rethorst","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0930","first-page":"21","article-title":"On the use of gamma-hydroxybutyrate of sodium in psychiatric therapy","volume":"22","author":"Rinaldi","year":"1967","journal-title":"Acta Neurol. (Napoli.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0935","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1901\/jeab.2012.97-323","article-title":"Preference for gamma-hydroxybutyrate (GHB) in current users","volume":"97","author":"Roll","year":"2012","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0940","first-page":"25","article-title":"Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men","volume":"11","author":"Romanelli","year":"2003","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0945","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0272-2712(18)30148-3","article-title":"Recreational drugs. Current trends in the 90s","volume":"18","author":"Ropero-Miller","year":"1998","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0950","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0740-5472(96)00157-2","article-title":"Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients","volume":"14","author":"Rosen","year":"1997","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0955","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1081\/JA-120017657","article-title":"Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men","volume":"38","author":"Ross","year":"2003","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0960","first-page":"1017","article-title":"The therapy of experimental influenza in mice with antibiotic lactones and related compounds","volume":"19","author":"Rubin","year":"1947","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0965","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0022-3565(25)10134-1","article-title":"Acute effects of triazolam and lorazepam on human learning: performance and subject ratings","volume":"264","author":"Rush","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0970","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.24142","article-title":"Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"60","author":"Russell","year":"2009","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0975","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","article-title":"Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study","volume":"152","author":"Russell","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0980","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/emj.14.4.259","article-title":"Gamma hydroxybutyrate\u2014a coma inducing recreational drug","volume":"14","author":"Ryan","year":"1997","journal-title":"J. Accid. Emerg. Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0985","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0278-5846(98)00018-9","article-title":"Growth hormone secretion during sleep in male depressed patients","volume":"22","author":"Sakkas","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0990","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib0995","first-page":"1986","article-title":"Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report","volume":"25","author":"Scharf","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1000","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","article-title":"Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients","volume":"21","author":"Scharf","year":"1998","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1005","first-page":"1070","article-title":"The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia","volume":"30","author":"ScharF","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00007611-200093060-00002","article-title":"Drug-facilitated sexual assault (\u2018date rape')","volume":"93","author":"Schwartz","year":"2000","journal-title":"South Med. J."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuint.2006.11.007","article-title":"Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats","volume":"50","author":"Sgaravatti","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11011-009-9136-7","article-title":"Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo","volume":"24","author":"Sgaravatti","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1086-5802(16)30472-7","article-title":"Drugs used in acquaintance rape","volume":"39","author":"Smith","year":"1999","journal-title":"J. Am. Pharm. Assoc. (Wash.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ajhp\/59.11.1067","article-title":"Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate","volume":"59","author":"Smith","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0165-3806(81)90010-9","article-title":"Ontogeny of gamma-hydroxybutyric acid. I. Regional concentration in developing rat, monkey and human brain","volume":"227","author":"Snead","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1045","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1471-4159.2000.0751986.x","article-title":"Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor","volume":"75","author":"Snead","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1050","first-page":"631","article-title":"Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy","volume":"31","author":"Sonka","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","article-title":"Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial","volume":"71","author":"Spaeth","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1060","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4375","article-title":"Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia","volume":"15","author":"Spaeth","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1065","first-page":"354","article-title":"Acute poisoning from gamma hydroxybutyrate (GHB)","volume":"92","author":"Steele","year":"1995","journal-title":"Mo Med"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.drugalcdep.2007.07.009","article-title":"Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB)","volume":"92","author":"Sumnall","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1075","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/jcem-44-5-1014","article-title":"Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans","volume":"44","author":"Takahara","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1080","first-page":"9","article-title":"Clinical application of 4-hydroxybutyrate sodium and 4-butyrolactone in neuropsychiatric patients","volume":"20","author":"Tanaka","year":"1966","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1085","first-page":"309","article-title":"Ecstatic anaesthesia: Ketamine and GHB between medical use and self-experimentation","volume":"16","author":"Teltzrow","year":"2012","journal-title":"Appl. Cardiopulm. Pathophysiol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.jcp.0000237944.57893.28","article-title":"Gamma-hydroxybutyrate and ethanol effects and interactions in humans","volume":"26","author":"Thai","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.clpt.6100037","article-title":"Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers","volume":"81","author":"Thai","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1100","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s10461-014-0779-y","article-title":"Drug use and sexual risk among gay and bisexual men who frequent party venues","volume":"18","author":"Theodore","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1105","first-page":"31","article-title":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy","volume":"26","author":"Us-Xyrem-Msc","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1110","series-title":"Public Law 106\u2014172\u2014Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000","author":"USGPO","year":"2000"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1115","series-title":"Information Bulletin: GHB Analogs GBL, BD, GHV, and GVL","author":"USNDIC","year":"2009"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/09595230500295725","article-title":"Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature","volume":"24","author":"Uys","year":"2005","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yrtph.2012.03.005","article-title":"Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands","volume":"63","author":"Van Amsterdam","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI119587","article-title":"Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men","volume":"100","author":"Van Cauter","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/15563650701365818","article-title":"Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series","volume":"45","author":"Van Sassenbroeck","year":"2007","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1389-9457(03)00059-5","article-title":"Sleep disorders and depressive feelings: a global survey with the Beck depression scale","volume":"4","author":"Vandeputte","year":"2003","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1145","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-4159.1985.tb04065.x","article-title":"Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro","volume":"45","author":"Vayer","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0031-9384(95)02127-2","article-title":"Effects of short- and long-term REM sleep deprivation on sexual behavior in male rats","volume":"59","author":"Velazquez-Moctezuma","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(00)00246-6","article-title":"Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat","volume":"397","author":"Vergoni","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pnpbp.2004.10.004","article-title":"Clinically relevant anterograde amnesia and its relationship with blood levels of benzodiazepines in suicide attempters who took an overdose","volume":"29","author":"Verwey","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.5665\/sleep.1992","article-title":"Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory","volume":"35","author":"Vienne","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1472-6963-13-185","article-title":"The use and costs of health and social services in patients with longstanding substance abuse","volume":"13","author":"Vossius","year":"2013","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1175","series-title":"Neue Untersuchungen Mit Gamma-Hydroxibutters\u00e4ure","article-title":"Pharmacokinetics of 4-hydroxybutyric acid in man, rhesus monkey and dog","author":"Vree","year":"1978"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/sleep\/33.9.1217","article-title":"Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss","volume":"33","author":"Walsh","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/29.9.1189","article-title":"A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy","volume":"29","author":"Weaver","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1190","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00213-004-2079-0","article-title":"Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons","volume":"179","author":"Weerts","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2013.12.067","article-title":"Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death","volume":"263","author":"Wendt","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1200","unstructured":"WHO 2012. Gamma-hydroxybutyric acid (GHB) Critical Review Report. In: E Xpert Committee On Drug Dependence, E. C. O. D. (ed.) WHO Thirty-fifth Meeting. Hammamet, Tunisia."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1205","doi-asserted-by":"crossref","first-page":"h6281","DOI":"10.1136\/bmj.h6281","article-title":"New health promotion for chemsex and gamma-hydroxybutyrate (GHB)","volume":"351","author":"Winstock","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(98)00153-7","article-title":"Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys","volume":"54","author":"Woolverton","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugalcdep.2006.01.002","article-title":"Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths","volume":"84","author":"Wu","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind: placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","author":"Xyrem International Study Group","year":"2005","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.sleep.2014.07.025","article-title":"Subjective deficits of attention: cognition and depression in patients with narcolepsy","volume":"16","author":"Zamarian","year":"2015","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainresbull.2016.02.002_bib1230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajem.2009.11.008","article-title":"Case series of 226 gamma-hydroxybutyrate-associated deaths: lethal toxicity and trauma","volume":"29","author":"Zvosec","year":"2011","journal-title":"Am. J. Emerg. Med."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923016300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923016300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:26:32Z","timestamp":1759782392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923016300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":246,"alternative-id":["S0361923016300156"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2016.02.002","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}